NASDAQ · CHMG

Chemung Financial Corp.

$80.50 -$0.48 (-0.59%) 1D Market open
Session Pulse After hours 1 mentions on Mon No new SEC filings since Tue close its sector ranked 4/11 this week Full pulse →
Charting by TradingView

Key Metrics

$390.31M
Market cap
21.35×
P/E · TTM
—
Revenue · TTM
$18.28M
Net income
EPS · TTM $3.82
Dividend yield 1.6%
Free cash flow $45.87M
Beta · 1Y 0.44
EBITDA · TTM $26.00M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    A material event was filed (Form 8-K).

    8-K - CHEMUNG FINANCIAL CORP (0000763563) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 24
    The stock moved +8.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 24
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 20
    The stock moved +8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 20

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$390.31M
Enterprise value—
Shares outstanding4.8M
52-wk range$48.61 – $82.86
Avg volume · 20D12.7K
Net cash —
Book value / share$54.88
IndustryState Commercial Banks
ExchangeNASDAQ
About Chemung Financial Corp.
IPO dateFeb 1, 1995
Employees348

Chemung Financial Corp is a bank holding firm.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E21.35
P/S—
P/FCF8.51
EV/EBITDA—
EV/Sales—
Graham №$68.64

Profitability

Gross —
Operating —
Net —
FCF —
ROE / ROIC 7.6% · 8.7%

Financial Health

Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital—

Cash Flow · TTM

Operating CF $47.36M
Capex −$1.49M
Free cash flow $45.87M
Buybacks $484.00K
Dividends paid $6.43M
Shareholder yield 1.8%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$68.64 vs $80.50
Trades 1.2× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings